Braden Michael Leonard sold $1.4M of Aclaris Therapeutics (ACRS)

Executed Apr 23, disclosed Apr 27, 4 days later.

Value, as filed

$1.4M

300,000 sh × $4.53

Executed

Apr 23

the trade date, as filed

Disclosed

Apr 27

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BL Braden Michael Leonard 10% owner profile →

Braden Michael Leonard (10% owner) filed 4 Form 4 reports in the trailing twelve months (1 purchase, 3 sales), most often in ADVM. Across 1 priced purchase filing, the average 21-session return was +36.7% from execution and +1.5% from disclosure (delay-adjusted; derived). The largest single filing was $2.4M of ADVM (574,886 sh across 3 lots, as filed), executed Dec 1 2025.

The name

ACRS ACRS ACRS · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→